534 related articles for article (PubMed ID: 30672843)
1. Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis.
Hellstrom WJG; Tue Nguyen HM; Alzweri L; Chung A; Virasoro R; Tapscott A; Ziegelmann M; Trost L; Gelbard M
J Urol; 2019 Apr; 201(4):777-782. PubMed ID: 30672843
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Curvature Improvement in Men With Peyronie's Disease Treated With Intralesional Collagenase Clostridium Histolyticum.
Flores JM; Nascimento B; Punjani N; Salter CA; Bernie HL; Taniguchi H; Miranda E; Terrier JE; Schofield E; Jenkins L; Mulhall JP
J Sex Med; 2022 Nov; 19(11):1680-1686. PubMed ID: 36127227
[TBL] [Abstract][Full Text] [Related]
3. Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease.
Ziegelmann MJ; Viers BR; McAlvany KL; Bailey GC; Savage JB; Trost LW
J Urol; 2016 Apr; 195(4 Pt 1):1051-6. PubMed ID: 26476353
[TBL] [Abstract][Full Text] [Related]
4. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase clostridium Histolyticum for Peyronie's Disease.
Goldstein I; Lipshultz LI; McLane M; Hu Y; Xiang Q; Liu G; Vijayan S; Gelbard MK
J Urol; 2020 Jun; 203(6):1191-1197. PubMed ID: 31922462
[TBL] [Abstract][Full Text] [Related]
6. Peyronie's disease response to intralesional collagenase clostridium histolyticum therapy is independent of baseline testosterone.
Schneider D; O'Leary M; Amini E; Miller J; Hassas N; Nguyen J; Hammad MAM; Barham D; Yafi FA
Andrology; 2024 May; 12(4):830-834. PubMed ID: 37753943
[TBL] [Abstract][Full Text] [Related]
7. Predictive Factors of Patients' and Their Partners' Sexual Function Improvement After Collagenase Clostridium Histolyticum Injection for Peyronie's Disease: Results From a Multi-Center Single-Arm Study.
Cocci A; Russo GI; Salonia A; Cito G; Regis F; Polloni G; Giubilei G; Cacciamani G; Capece M; Falcone M; Greco I; Timpano M; Minervini A; Gacci M; Cai T; Garaffa G; Giammusso B; Arcaniolo D; Mirone V; Mondaini N
J Sex Med; 2018 May; 15(5):716-721. PubMed ID: 29699756
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
Ralph DJ; Abdel Raheem A; Liu G
J Sex Med; 2017 Nov; 14(11):1430-1437. PubMed ID: 28974406
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.
Gelbard M; Goldstein I; Hellstrom WJ; McMahon CG; Smith T; Tursi J; Jones N; Kaufman GJ; Carson CC
J Urol; 2013 Jul; 190(1):199-207. PubMed ID: 23376148
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Combined Collagenase Clostridium histolyticum and RestoreX Penile Traction Therapy in Men with Peyronie's Disease.
Alom M; Sharma KL; Toussi A; Kohler T; Trost L
J Sex Med; 2019 Jun; 16(6):891-900. PubMed ID: 30956106
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute-Phase Peyronie's Disease.
Nguyen HMT; Anaissie J; DeLay KJ; Yafi FA; Sikka SC; Hellstrom WJG
J Sex Med; 2017 Oct; 14(10):1220-1225. PubMed ID: 28874331
[TBL] [Abstract][Full Text] [Related]
12. Long-term Curvature Deformity Characterization in Men Previously Treated With Collagenase Clostridium Histolyticum for Peyronie's Disease, Subgrouped by Penile Plaque Calcification.
Goldstein I; McLane MP; Xiang Q; Wolfe HR; Hu Y; Gelbard MK
Urology; 2020 Dec; 146():145-151. PubMed ID: 32896582
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute Phase Peyronie's Disease: A Multi-institutional Analysis.
Nguyen HMT; Yousif A; Chung A; Virasoro R; Tapscott A; Ziegelmann M; Trost L; Gelbard M; Hellstrom WJG
Urology; 2020 Nov; 145():147-151. PubMed ID: 32777367
[TBL] [Abstract][Full Text] [Related]
14. Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.
Levine LA; Larsen SM
J Sex Med; 2015 Jan; 12(1):259-64. PubMed ID: 25345351
[TBL] [Abstract][Full Text] [Related]
15. Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol.
Abdel Raheem A; Capece M; Kalejaiye O; Abdel-Raheem T; Falcone M; Johnson M; Ralph OG; Garaffa G; Christopher AN; Ralph DJ
BJU Int; 2017 Nov; 120(5):717-723. PubMed ID: 28612401
[TBL] [Abstract][Full Text] [Related]
16. Continuing Collagenase Clostridium Histolyticum Injections Among Initial Nonresponders Results in Significant Curvature Improvements in the Majority of Peyronie's Disease Men.
Alom M; Burgon H; Ziegelmann M; Köhler T; Helo S; Trost L
J Sex Med; 2021 Jun; 18(6):1092-1098. PubMed ID: 34020925
[TBL] [Abstract][Full Text] [Related]
17. Second cycle of intralesional Collagenase Clostridium histolyticum for Peyronie's disease using the modified shortened protocol: Results from a retrospective analysis.
Capece M; Arcaniolo D; Manfredi C; Palmieri A; De Sio M; Verze P; Fusco F; Longo N; Mirone V
Andrologia; 2020 Apr; 52(3):e13527. PubMed ID: 32003061
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Collagenase Clostridium histolyticum (Xiapex
Cocci A; Di Maida F; Russo GI; Capogrosso P; Francesco L; Rizzo M; Di Mauro M; Salonia A; Cito G; Falcone M; Romano A; Polloni G; Martinez-Salamanca JI; Fernández-Pascual E; Minervini A; Mondaini N
Clin Drug Investig; 2020 Jun; 40(6):583-588. PubMed ID: 32342279
[TBL] [Abstract][Full Text] [Related]
19. Collagenase Clostridium histolyticum Treatment Improves Degree of Curvature in Peyronie's Disease with Calcified Plaques.
Masterson TA; Atuluru P; Zucker I; Molina M; Ibrahim E; Nackeeran S; Kava B; Ramasamy R
Eur Urol Focus; 2023 Jan; 9(1):55-59. PubMed ID: 36272924
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies.
Lipshultz LI; Goldstein I; Seftel AD; Kaufman GJ; Smith TM; Tursi JP; Burnett AL
BJU Int; 2015 Oct; 116(4):650-6. PubMed ID: 25711400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]